Tue, January 8, 2019
Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $67 on, Dec 18th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-67-on-dec-18th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $68 to $67 on, Dec 18th, 2018.

Matthew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kristen Stewart of "Barclays" Initiated at Hold and Held Target at $69 on, Tuesday, October 16th, 2018

Publication Contributing Sources